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Tetrabromobisphenol A has Immunosuppressive Effects on
Human Natural Killer Cells
Esther Caroline Kibakaya, Krishna Stephen, and Margaret M. Whalen
Department of Chemistry, Tennessee State University, Nashville, TN 37209
Abstract
Human natural killer (NK) cells are lymphocytes that destroy tumor cells, virally infected cells, and
antibody-coated cells. Tetrabromobisphenol A (TBBPA) is used both as a reactive and an additive
flame retardant in a variety of materials and appears to contaminate the environment. TBBPA has
been found in human blood samples and if it interferes with NK cell function, this could increase
risk of tumor development and/or viral infection. This study examines the effects of exposure to
various concentrations of TBBPA for 24 hr, 48 hr, and 6 d on the lytic function, tumor-target-binding
function, and ATP levels of NK cells. These same parameters were also monitored in NK cells that
were exposed to TBBPA for 1 hr followed by 24 hr, 48 hr, and 6 d in TBBPA-free media. A 24 hr
exposure of NK cells to 5 μM TBBPA caused a greater than 95% decrease in NK lytic function, a
70% decrease in binding function, and a 34% decrease in ATP levels in NK cells. Exposure to 2.5
μM TBBPA for 24 hr decreased lytic function by 76%, binding function by 20%, and had no effect
on ATP levels. Exposure of NK cells to 5 μM TBBPA for 1 hr followed by 24 hr in TBBPA-free
media caused a progressive and persistent loss of lytic function (41%) while not affecting either
binding ability or ATP levels. The results indicate that TBBPA exposures decrease the lytic function
of human NK cells and that an initial brief (1 hr) exposure can cause a progressive loss of function.
Additionally, the data also indicate that TBBPA-induced loss of NK lytic function can occur at
concentration of TBBPA that do not affect target-binding ability and ATP levels of NK cells.
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Introduction
Tetrabromobisphenol A (TBBPA) is used as a flame retardant in a wide variety of materials
including plastics, paper, and textiles (IPCS/WHO, 1995; HSBD, 2001). TBBPA has been
used as a replacement for the polybrominated diphenylethers (PBDEs), whose persistence in
the environment and potential for negative effects on health have prompted concerns (Sjodin
et al., 1999; Eriksson et al, 2001). Its main use is as a reactive flame retardant in epoxy resin
circuit boards (IPCS/WHO, 1995; HSDB, 2001). However, it is also applied to carpeting and
upholstery (Gain, 1997). TBBPA has additional uses as a plasticizer and as an intermediate in
the production of other flame retardants (IUPCS/WHO, 1995; HSBD, 2001). In 1998, the
annual U.S. production of TBBPA was greater than 1 million pounds with estimates ranging
between 100-500 million pounds (U.S. EPA, 2000a; Environ Defense, 2001). Its production
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and use have the potential to release TBBPA into the environment. It is a highly hydrophobic
compound and would be expected to absorb onto suspended solids and sediment in streams
(U.S. EPA, 1999, 2002b). Its half-life in water is expected to be 48-84 days (U.S. EPA,
1999, 2000b). TBBPA is found in sewage sludge (Sellstrom and Jannson, 1995; de Boer et al.,
2002; de Wit, 2002;) and appears to bioaccumulate (IPCS/WHO, 1995; HSBD 2001; Birnbaum
and Staskal, 2004).
TBBPA has been found in human serum samples (Hagmar et al., 2000; Nagayama et al.,
2001; Thomsen et al., 2002). Levels reported were 0.24-0.71 ng/g lipid in serum samples from
Norway (approximately 1.8-5.3 pM, using a conversion factor of 400 mg lipid/100ml serum)
(Thomsen et al., 2002) and averaged 4.5 ng/g lipid (approximately 33.8 pM) in a Japanese
study (Nagayama et al., 2001). A toxicokinetic study following a single oral dose of 300 mg/
kg TBBPA to adult humans showed a peak plasma concentration of 103 μM within 3 hr that
declined, with an elimination half-life of 13 hr (Schauer et al., 2006). Human exposure to
TBBPA is believed to occur by inhalation, dermal contact, and ingestion (IPCS/WHO, 1995;
Peterman et al., 2000). It has been found in commercial drinking water that was stored in
polycarbonate containers (Peterman et al., 2000) and in seafood (IPCS/WHO, 1995). There
has been little study of the toxicological effects of TBBPA on humans. However there have
been studies of its effects in rodents and rainbow trout. TBBPA was shown to increase the
activity of glutathione reductase in rainbow trout (Ronisz et al., 2004). In mice it has been
shown to cause decreases in serum proteins and red blood cells as well as increases in spleen
weight (IPCS/WHO, 1995). Administration of TBBPA to newborn rats caused polycystic
kidney lesions (Fukuda et al., 2004). Administration of TBBPA to Wistar rats showed effects
on circulating thyroid hormone, T4, levels (Van der Ven et al., 2008). This same study showed
that there were no effects of TBBPA exposure on the function of splenic natural killer (NK)
cells in exposed rats or their offspring (Van der Ven et al., 2008). In vitro studies of TBBPA
showed that it was able to compete with thyroid hormone, T4, for binding to human
transthyretin (thyroid hormone transport protein) (Meerts et al., 2000).
Human NK cells are immune system cells (lymphocytes) that are capable of destroying tumor
cells, virally infected cells, and antibody-coated cells. NK cells have the markers CD56 and/
or CD16 on their cell surface and lack the T-lymphocyte receptor/CD3 complex (Lotzova,
1993). NK cells are a crucial immune defense against malignant neoplasms and viral infections
(Lotzova, 1993; Vivier et al., 2004). Their role in protecting against viral infections is
demonstrated by increased incidences of viral infection in individuals that lack NK cells
(Fleisher et al., 1982; Biron et al., 1989). Unlike T-lymphocytes, NK cells lyse (destroy)
appropriate target cells without prior sensitization making them a frontline immune defense.
Thus, if a compound such as TBBPA were to alter NK-cell function, this could result in
increased risk of viral infection and tumor formation. A recent study has shown that another
flame retardant inhibits the function of human NK cells (Hinkson and Whalen, 2009).
Suppression of human NK cell function by contaminants such as these may account in part for
increases in cancer incidence that have been seen, especially those seen in lymphomas and
leukemias (SEER, 2009). Thus, it is important to address capacity of TBBPA as well as other
environmental contaminants to diminish the function of human NK cells.
In the current study TBBPA was examined for its potential to disrupt the lytic function of NK
cells. Both acute (i.e., 1 hr) and chronic (as long as 6 d) exposures were examined. The brief
(1 hr) exposures were followed by periods of time in TBBPA-free media prior to assessing NK
function (1 hr exposures, followed by up to 6 d in TBBPA-free media). These types of studies
were important in that lasting (or developing) negative effects of a brief exposure to TBBPA
would suggest greater risk from exposure to the compound. Finally, the effects of TBBPA on
the ability of NK cells to bind to their target cells and on the intracellular ATP levels in NK
cells were studied. Binding of NK cells to targets is a necessary step in the lytic process and
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interference with binding could lead to loss of lytic function (Lotzova et al., 1993).
Additionally, NK lytic function is an ATP dependent process (Andzelm et al., 2007), and
decreases in ATP could lead to loss of lytic function.
Materials and Methods
Isolation of NK cells
Peripheral blood from healthy adult (male and female) volunteer donors was used for this study.
Buffy coats (source leukocytes) obtained from the American Red Cross (Portland, OR) or Key
Biologics, LLC (Memphis, TN) were used to prepare NK cells. Highly-purified NK cells were
obtained using a rosetting procedure. Buffy coats were mixed with 0.8 ml of RosetteSep human
NK cell enrichment antibody cocktail (StemCell Technologies, Vancouver, British Columbia,
Canada) per 45 ml of buffy coat. The mixture was incubated for 20 min at room temperature
(~25°C). Following the incubation, 7-8 ml of the mixture was layered onto 4 ml of Ficoll-
Hypaque (1.077 g/ml; MP Biomedicals, Irvine, CA) and centrifuged at 1200 × g for 30-40 min.
The cell layer was then collected and washed twice with phosphate-buffered saline (PBS; pH
7.2) and stored in complete media (RPMI-1640 supplemented with 10% heat-inactivated
bovine calf serum [BCS], 2 mM L-glutamine, and 50 U penicillin G\50 μg streptomycin/ml) at
1 million cells/ml (Whalen et al., 2002).
Chemical preparation
TBBPA (purchased from Fisher Scientific, 97% pure) was dissolved in dimethyl sulfoxide
(DMSO) (Sigma-Aldrich, St. Louis, MO) to yield a 100 mM stock solution. Desired
concentrations of TBBPA were then prepared by dilution of the stock into complete media
containing 0.5% gelatin in the place of 10% bovine serum. Gelatin was used in place of bovine
serum to avoid binding of TBBPA to the serum’s albumin, which could interfere with its
delivery the cells. The final concentration of DMSO in any of the TBBPA exposures did not
exceed 0.01%.
Cell Treatments
NK cells (at a concentration of 1.5 × 106 cells/ml) were exposed to TBBPA or control (DMSO-
bearing medium) for 24 hr, 48 hr, or 6 d. Following exposures, the cells were assayed for tumor-
destroying function, binding function, and/or ATP levels. Additionally, NK cells were exposed
to TBBPA for 1 hr; following the 1-hr exposure period, the TBBPA-containing or control
media was removed and replaced with fresh TBBPA-free media and the cells were incubated
in compound-free media for 24 hr, 48 hr, or 6 d prior to being assayed for tumor-destroying
function, binding function, and/or ATP levels. The concentration range examined was 0.05 -
10 μM TBBPA.
Cell Viability
Cell viability was determined by trypan blue exclusion. Cell numbers and viability were
assessed at the beginning and end of each exposure period. Viability was determined at each
concentration for each of the exposure periods. The viability of treated cells was then compared
to that of control cells at each length of exposure (Whalen et al., 2003). Only those
concentrations where viability was unaffected were used at a given length of exposure.
Viability was 100% of that seen in the control NK cells at the concentrations used at a specific
exposure time.
Cytotoxicity assay
The ability of NK cells to lyse tumor cells was measured using a 51Cr release assay (Whalen
et al., 1999). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human
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chronic myelogenous leukemia) cell line. Briefly, K562 cells were incubated with 51Cr (Perkin-
Elmer Life Sciences, Boston, MA) in 0.2 - 0.5 ml of unadulterated BCS (BCS containing no
additions) for 1-1.5 hr at 37 °C in an air:CO2 (19:1) incubator. Following this incubation, the
target cells were washed twice with gelatin media. NK (effector) cells (1.2 × 105/100 μl for
12:1 ratio with target cells) were added to the wells of round-bottom micro-well plates. The
effector cells were diluted to a 6:1 (0.6 × 105/100 μl) and a 3:1 ratio (0.3 × 105/100 μl); each
ratio was tested in triplicate. Target cells were added (1 × 104/100 μl) to each well of the micro-
well plate; the plate was then centrifuged at 300 × g for 3.5 min and incubated for 2 hr at 37 °
C (air:CO2, 19:1). After this incubation, a 0.1 ml aliquot of supernatant was collected from
each well and each assessed for radioactivity (in 60 sec) in a Packard COBRA γ- radiation
counter (Packard Instrument Co., Meriden, CT). Target lysis was then calculated as: 100 ×
[test cpm - spontaneous cpm]/[maximum cpm - spontaneous cpm]. Maximum release was
produced by adding 100 μl of 10% Triton X-100 to wells containing only the labeled target
cells; spontaneous release was assessed from wells containing cells plus medium only.
Binding Assay
The percentage of target cells with bound NK cells was determined at two effector:target ratios,
i.e., 12:1 and 6:1. The NK cells were treated as described above for the cytotoxicity assay.
Tumor cells were then incubated with an appropriate number of control or TBBPA exposed
lymphocytes in round-bottomed micro-well plates (20,000 tumor cells/well). Each condition
was tested in triplicate. The cells were incubated at 37° C (air:CO2, 19:1) for 10 min and then
placed on ice. Following the incubation period, the cells were gently re-suspended with a
micropipette, placed in a hemocytometer and viewed under a light microscope. The number
of target cells with two or more lymphocytes bound to their surface was counted as well as the
total number of targets to determine the percentage of tumor cells with lymphocytes bound.
The minimum number of targets counted per determination was 50-100 (Whalen et al.,
1999).
ATP Assay
Following exposures of cells to the various concentrations of TBBPA; 250,000 NK cells were
added to 300 μl of somatic cell ATP releasing reagent (Sigma-Aldrich). To measure ATP, 100
μl of lysed cell suspension was added to 100 μl of a Luciferin/Luciferase mixture (Sigma). The
light emission was then measured using a Fluoroskan Ascent FL luminescence plate reader
(Thermo Electron Corp., Vantaa, Finland). ATP levels were then determined by extrapolation
from a standard curve (Dudimah et al., 2007b).
Statistical Analysis
The data from TBBPA treated cells at a given concentration were compared to control data by
pair wise analysis using Student’s t-test (Figures 1, 3, 5, and 6). Two-way ANOVA, as well
as post-hoc linear regression, were used to evaluate the effect of length of exposure at a given
concentration of TBBPA in Figures 2 and 4.
Results
Lytic Function and Binding Function of NK Cells Exposed to TBBPA for 24 hr, 48 hr, and 6
d
Exposures of NK cells to 2.5 and 5 μM TBBPA for 24 hr caused very significant reductions
in NK cell lytic function of 75.8 ± 6.6% and 96.2 ± 3.1%, respectively (p < 0.0001) (Figure
1A). The decrease in lytic function after a 24 hr exposure to 1 μM TBBPA was 38.6 ± 10.7%
(p < 0.001), while that at 0.5 μM was 23.3 ± 11.2% (p < 0.001). The binding function of NK
cells exposed to 2.5 and 5 μM TBBPA for 24 hr was reduced by 19.1 ± 14.3% and 69.9 ±
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16.6%, respectively (p < 0.0001) (Figure 1A). NK cells exposed to 1 μM TBBPA for 24 hr
showed no loss of binding function.
NK cells were exposed to concentrations of 0.25 - 2.5 μM TBBPA for 48 hr because higher
concentrations caused decreased viability of the NK cells. Exposure at all of the concentrations
tested except 0.25 μM TBBPA caused significant decrease in the lytic function of NK cells.
The decreases were 31.0 ± 9.8% at 0.5 μM, 56.0 ± 7.1% at 1 μM, and 86.1 ± 6.3% at 2.5 μM
(p < 0.0001) (Figure 1B). NK cells that were exposed to concentrations below 1 μM TBBPA
showed no loss of binding function. A 48 hr exposure to 1 μM TBBPA caused a small loss of
binding function of 12.2 ± 11.0% (p < 0.05). Exposure to 2.5 μM TBBPA for 48 hr caused a
decrease in binding function of 51.2 ± 18.7% (p < 0.0001) (Figure 1B).
The 6-d exposures of NK cells to TBBPA were carried out at concentrations of 0.05 μM -1
μM. There was a significant decrease in tumor-cell-lysing function with a 6 d exposure to all
of the concentrations of TBBPA except the 0.05 μM (Figure 1C). TBBPA caused decreases in
lytic function of 20.3 ± 16.0% at 0.1 μM, 33.2 ± 19.1% at 0.25 μM, 63.7 ± 21.4% at 0.5 μM,
and 89.2 ± 16.0% at 1 μM (p < 0.01) (Figure 1C). NK cells exposed to 0.25 - 1 μM TBBPA
for 6 d showed a significant decrease in binding function (33.2 ± 23.7%, p < 0.01) only with
the 1 μM exposure (Figure 1C).
Figure 2 plots the lytic function of NK cells exposed to 0.5 and 1 μM TBBPA as a function of
length of exposure (using the data from Figure 1). Only the 0.5 and 1 μM TBBPA
concentrations are shown as these are the only concentrations that were tested at all three
lengths of exposure. This is done to show that there appears to be an increased loss of lytic
function with length of exposure at a given concentration of TBBPA, when comparing the 24
hr exposures to the 6 d exposures (p < 0.01).
Lytic Function and Binding Function of NK Cells Exposed to TBBPA for 1 hr, Followed by 0
hr, 24 hr, 48 hr, and 6 d in TBBPA-Free Medium
In order to assess whether a brief exposure of NK cells to TBBPA could cause lasting and/or
ensuing affects on lytic or binding function, NK cells were exposed to 0.5 - 10 μM TBBPA
for 1 hr which was removed and the NK cells were then suspended in TBBPA-free media for
0 hr, 24 hr, 48 hr, or 6 d before assaying for lytic function or binding function. NK cells exposed
to 10 μM for 1 hr and then tested immediately for lytic function (0 hr in TBBPA- free media)
exhibited a statistically-significant decreases in lytic function of 30.1 ± 12.5% (p < 0.001)
lower concentrations caused no significant decreases in lytic function. When NK cells were
exposed to 0.5 - 10 μM, TBBPA for 1 hr and then incubated in TBBPA-free media for 24 hr
prior to assaying for lytic function, decreases in lytic function of 22.4 ± 9.9% (1 μM), 27.0 ±
11.3% (2.5 μM), 41.4 ± 10.9% (5 μM), and 53.9 ± 15.0% (10 μM) (p < 0.001) were seen (Figure
3A). The binding function of NK cells exposed to TBBPA for 1 hr, followed by 24 hr in
TBBPA-free media prior to assaying for binding function was unaffected by any of the
concentrations tested (Figure 3A).
NK cells exposed to these same concentrations of TBBPA and incubated for 48 hr in TBBPA-
free media prior to assay, showed reductions in lytic function of 18.3 ±1 8.9% (2.5 μM), 22.6
± 14.7% (5 μM), and 37.4 ± 11.7% (10 μM) (p < 0.05) (Figure 3B). The binding function of
NK cells exposed to TBBPA for 1 hr, followed by 48 hr in TBBPA-free media prior to assaying
for binding function was unaffected by any of the concentrations tested (Figure 3B).
In NK cells exposed to these same concentrations of TBBPA for 1 hr, followed by a 6-d period
in TBBPA-free media lytic function decreased 33.6 ± 23.5% (2.5 μM), 41.2 ± 9.9% (5 μM),
and 64.3 ± 6.7% (10 μM) (p < 0.01) (Figure 3C). NK cells that were exposed to 10 μM TBBPA
for 1 hr and then given 6 d in TBBPA-free media prior to assaying for binding function showed
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a loss of binding function of 49.6 ± 8.4% (p < 0.0001) (Figure 3C). All other concentrations
tested 6 d following 1 hr exposures to TBBPA showed no loss of binding function (Figure 3C)
Figure 4 plots the results of 1 hr exposures to 5 and 10 μM TBBPA followed by 0 hr, 24 hr,
48 hr, and 6 d in TBBPA-free media as a function of length of time in TBBPA-free media (such
as was done in Figure 2). There again appears to be an increasing loss of lytic function with
time after a 1 hr exposure (p < .0.01).
ATP Levels in NK Cells Exposed to TBBPA for 24 hr, 48 hr, and 6 d
NK cells exposed to TBBPA for 24 hr showed no significant decreases in ATP levels except
at 5 μM where ATP was decreased by 33.5 ± 12.6% (p < 0.0001) (Figure 5A). Lytic function
data from Figure 1 were placed on the plots of ATP changes (Figure 5) in order to facilitate
comparison of changes in ATP levels with those of lytic function. Reduction in ATP levels of
16.8 ± 9% and 32.7 ± 8.4% were seen with 48 hr exposures to 1 and 2.5 μM HBCD, respectively
(p < 0.0001) (Figure 5B). A 6-d exposure of NK cells to 0.25, 0.5, and 1 μM HBCD led to
decreases in ATP levels of 38.4 ± 15%, 55.6 ± 29.6%, and 78.3 ± 27.2%, respectively (p <
0.001) (Figure 5C).
Effects of Exposures to TBBPA for 1 hr Followed by, 24 hr, 48 hr, and 6 d in TBBPA-Free
Media on ATP Levels in NK Cells
As with lytic function and binding function, it is possible that an initial exposure to TBBPA
for 1 hr could cause changes in NK cell ATP levels that would manifest later, even though the
compound has been removed. Thus, we examined if the effects of exposures to TBBPA
intensified following removal of the compound. To address this possibility, NK cells were
exposed to 0.5 - 10 μM TBBPA for 1 hr that was then removed and the NK cells were then
suspended in TBBPA-free media for 24 hr, 48 hr, or 6 d before assaying for ATP levels. NK
cells exposed to TBBPA for 1 hr and then incubated for 24 hr in TBBPA-free media prior to
measuring ATP levels showed no significant decreases in ATP levels (Figure 6A). As was
done above, lytic function data from Figure 3 were placed on the plots of ATP changes (Figure
6) in order to facilitate comparison of changes in ATP levels with those of lytic function. NK
cells exposed to 2.5, 5 and 10 μM TBBPA for 1 hr and given a 48 hr period in TBBPA-free
media before assay showed very small decreases in ATP levels (p < 0.05) (Figure 6B). A 1 hr
exposure of NK cells to 1-10 μM TBBPA followed by 6 d in TBBPA-free media lead to
decreases in ATP of about 30% at the 1 - 5 μM concentrations of TBBPA and of 43.6 ± 39.6%
at 10 μM (p < 0.01) (Figure 6C).
Discussion
Chemically-induced diminution of human NK cell immune function could leave an individual
vulnerable to malignant neoplasias and/or viral infection. Previous studies have indicated that
humans with a defect that leaves their NK cells unable to lyse target cells have a predisposition
to development of certain tumors (Ortaldo et al., 1992) and that individuals lacking NK cells
had severe herpes virus infection (Biron et al., 1989) and Epstein-Bar infections (Fleisher, et
al., 1982). Studies in mice have shown that a decrease in NK cell activity of 80% results in an
increase in tumor formation upon challenge with melanoma cells (Wilson et al., 2001).
Decreased NK cell function and increased tumor metastases have been demonstrated in mice
exposed to cigarette smoke (Lu et al., 2007) and exposure of mice to the chemical urethane
causes tumors and has been shown to suppress NK function (Luebke et al., 1986).
A large number of chemicals currently contaminate the environment and are found in human
tissues (Thornton et al. 2002). The use of TBBPA as a flame retardant and plasticizer (HSBD,
2001; IPCS/WHO, 1995) has resulted in its being found in human blood samples (Hagmar et
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al., 2000; Nagayama et al., 2001; Thomsen et al., 2002). While it appears to be eliminated to
some extent from the human system (Schauer et al., 2006), its detection in human blood samples
indicates that a certain fraction accumulates in the body. Levels of TBBPA in human serum
of 4.5 ng/g lipid (33.8 pM, using 400 mg lipid per 100 ml serum) have been reported (Nagayama
et al., 2001). We examined the effects of TBBPA exposures on the lytic function of human
NK cells. Further, the ability of an initial exposure to TBBPA to cause lasting and/or ensuing
disruption of lytic function was examined, as a lasting disruption of NK function by a brief
encounter with TBBPA would indicate a greater level of potential harm from exposure to this
compound. The mechanism of TBBPA-induced decreases in lytic function was also addressed
by examining the effects of TBBPA on the ability of NK cells to bind to tumor target cells and
on ATP levels in NK cells. NK cells must first bind to target cells before they can initiate the
process by which the target is lysed (Lotzova, 1993; Vivier et al. 2004). ATP plays an important
role in lysis of tumor cells by NK cells (Andzelm et al., 2007).
A 24 hr exposure to as little as 0.5 μM TBBPA caused a significant loss of lytic function in
NK cells. When the concentration was 5 μM there was a nearly complete loss of lytic function
at 24 hr. These decreases in lytic function were not accompanied by comparable losses in
binding function. While exposure to 2.5 μM TBBPA for 24 hr caused a loss of lytic function
of about 76% the loss of binding function was only 19%. Thus, these studies indicate that the
TBBPA-induced loss of lytic function cannot be accounted for simply by TBBPA causing
reduced ability of the NK cells to bind to their tumor targets.
An important finding of the current study was that a brief exposure to TBBPA could cause
alteration(s) of the NK cell such that the loss of lytic function persisted and/or developed after
the compound was removed. An exposure to 10 μM TBBPA for 1 hr caused a 30% loss of lytic
function while lower concentrations had no effect on lytic function. When cells were tested 24
hr following the 1-hr exposures, there was a 54% loss of lytic function at 10 μM TBBPA. A 1
hr exposure to 5 μM TBBPA caused no loss of lytic function; however, 24 hr after that exposure,
the NK cells had lost 41% of their lytic ability. There was no loss of ability of NK cells to bind
to target cells 24 hr after a 1 hr exposure to any of the concentrations of TBBPA that were
tested. Thus, as was seen with continuous exposures to TBBPA loss of lytic function was not
accompanied by a concomitant loss of binding function.
Since a loss of binding function could not account for the losses of lytic function seen with
TBBPA exposures, we went on to examine whether TBBPA caused decreases in the
intracellular ATP levels of NK cells. As mentioned earlier, ATP is required for the release of
cytotoxic proteins from the NK cells onto target cells (Andzelm et al., 2007). As with binding
function we found that a decrease in ATP levels did not necessarily accompany a loss of lytic
function in TBBPA-exposed NK cells. For instance a 24 hr exposure to 2.5 μM TBBPA caused
a nearly 80% loss of lytic function without having any effect on ATP levels. We did find that
after a 6-d exposure to TBBPA the loss of lytic function was associated with a decrease in ATP
levels.
The current study indicates that exposures to TBBPA can cause very significant losses of
human peripheral blood NK cell lytic function. However, a recent study in Wistar rats found
that in vivo exposure to TBBPA had no effect on the function of splenic natural killer (NK)
cells in exposed rats or their offspring (Van der Ven et al., 2008). As mentioned, this study
examined the function of NK cells from the spleen and did not examine peripheral blood NK
cells. A previous study indicated that in vivo exposure of rats to the chemical carcinogens,
diethynitrosamine and 2-acetylaminofluorene, decreased the function of peripheral blood NK
cells but had no effect on splenic NK cells (Leu et al., 1985). Thus, the difference between
splenic and peripheral blood NK cells may be a potential explanation for the fact that TBBPA
dramatically decreased human NK cell lytic function but did not decrease the NK function in
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rats. Additionally, species differences in susceptibility to TBBPA as well as exposure levels
may also account for the differing results between rats and humans.
Previous studies have shown that a variety of environmental contaminants cause decreases in
NK cell function that persist once the compound is removed. These include another brominated
flame retardant, hexabromocylododecane (HBCD) (Hinkson and Whalen, 2009), several
organotin compounds (tributyltin [TBT], dibutyltin [DBT], and triphenyltin [TPT]) (Whalen
et al., 2002; Dudimah et al., 2007a,b; Whalen et al., 2003) an organochlorine compound,
pentacholorphenol (PCP) and a carbamate compound, ziram (Taylor et al., 2005). As with
TBBPA, neither a decrease in target binding nor a decrease in ATP levels could fully account
for the losses of lytic function seen with many of these compounds (HBCD, TBT, DBT, PCP,
ziram) (Whalen et al., 1999, 2002; Dudimah et al., 2007a,b; Taylor et al., 2005; Hinkson and
Whalen, 2009; Taylor and Whalen, 2009). However, as seen with TBBPA a decrease in ATP
appears to be associated with the loss of function seen after 6 d with some of these compounds
(HBCD, TBT, DBT, and PCP) (Dudimah et al., 2007a,b; Nnodu and Whalen, 2008; Hinkson
and Whalen, 2009).
While significant decreases in NK lytic function were seen in human NK cells exposed to
TBBPA, the concentrations at which these losses of function were seen were high compared
to what has been measured in human serum (Nagayama et al., 2001). However, because the
effects of TBBPA exposure do not subside once the compound is removed, there may be
potential for cumulative effects over time.
In summary, the data indicate that exposure of NK cells to TBBPA can cause very significant
losses of NK lytic function. Further, loss of lytic function occurs after a brief (1 hr) exposure,
indicating that the process(es) is/are stimulated during a brief exposure that lead to a sustained
loss of lytic function. TBBPA has effects on the ability of NK cells to bind to their targets and
also is able to decrease intracellular levels of ATP under certain conditions. However, decreases
in binding or in ATP levels cannot explain the losses of lytic function seen under several
conditions. The current study shows that TBBPA interferes with the essential immune function
of NK cells and thus has the potential for increasing the risk of cancer development in exposed
individuals.
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Figure 1. Effects of TBBPA exposures on the ability of NK cells to lyse or bind tumor cells
NK cells were exposed to 0.05 - 5 μM TBBPA for (A) 24 hr, (B) 48 hr, or (C) 6 d, and the
tested for lytic function (◆) or binding function (■). To combine results from separate
experiments (using cells from different donors), levels of lysis or binding were normalized as
the percentage of the lytic or binding function of the control cells (untreated cells from the
same donor) in a given experiment. Results were pooled from three separate experiments using
different donors (triplicate determinations for each experiment; n = 9; mean ± SD). Significant
decreases in Lytic Function as compared to control: (A) 0.5, 1, 2.5 and 5 μM (p < 0.001);
(B) 0.5, 1, and 2.5 μM (p < 0.0001); and, (C) 0.1, 0.25, 0.5, and 1 μM at (p < 0.01). Significant
decreases in Binding Function as compared to control: (A) 2.5 and 5 μM (p < 0.0001); (B) 1
and 2.5 μM (p < 0.05); and, (C) 1 μM (p < 0.01).
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Figure 2. Time course of the effects of 0.5 μM (black bar) and 1 μM (gray bar) TBBPA on the ability
of NK cells to lyse tumor cells
Results are the 0.5 and 1 μM data from Figure 1 plotted versus length of exposure.
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Figure 3. Effects of a 1-hr exposure to TBBPA followed by various periods in TBBPA-free media
on the ability of NK cells to lyse or bind tumor cells
NK cells were exposed to 0.5 - 10 μM TBBPA for 1 hr, and then tested for lytic function
(◆) or binding function (■) after (A) 24 hr, (B) 48 hr, or (C) 6 d. Results were normalized as
described in Figure 1. Significant decreases in Lytic Function as compared to control: (A) 1,
2.5, 5 and 10 μM (p < 0.001); (B) 2.5, 5, and 10 μM (p < 0.05); (C) 2.5, 5, and 10 μM at (p <
0.01). Significant decreases in Binding Function as compared to control: (A) none; (B) none;
and, (C) 10 μM (p < 0.0001).
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Figure 4. Time course of the effects of 1-hr exposures to 5 μM (black bar) and 10 μM (gray bar)
TBBPA followed by a period in TBBPA-free media on the ability of NK cells to lyse tumor cells
Results are the 5 and 10 μM data from Figure 3 plotted versus length of time in TBBPA-free
media.
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Figure 5. Effects of TBBPA exposures on the ATP levels and lytic function of NK cells
NK cells were exposed to 0.05 - 10 μM TBBPA for (A) 24 hr, (B) 48 hr, or (C) 6 d, and then
tested for ATP levels (■) or lytic function (◆). Results were normalized as described in Figure
1. Significant decreases in ATP levels as compared to control: (A) 5 μM (p < 0.0001); (B) 1
and 2.5 μM (p < 0.0001); and, (C) 0.25, 0.5 and 1 μM (p < 0.001). Significant decreases in
Lytic Function as compared to control: (A) 0.5, 1, 2.5 and 5 μM (p < 0.001); (B) 0.5, 1, and
2.5 μM (p < 0.0001); and, (C) 0.1, 0.25, 0.5, and 1 μM at (p < 0.01).
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Figure 6. Effects of TBBPA exposures on the ATP levels and lytic function of NK cells
NK cells were exposed to 0.5 - 10 μM TBBPA for 1 hr, followed by periods of time in TBBPA-
free media prior to assaying for ATP levels (■) or lytic function (◆). (A) 24 hr, (B) 48 hr, or
(C) 6 d. Results were normalized as described in Figure 1. Significant decreases in ATP
Levels as compared to control: (A) none; (B) 2.5, 5, and 10 μM (p < 0.05); and, (C) 1, 2.5, 5,
and 10 μM (p < 0.01). Significant decreases in Lytic Function as compared to control: (A) 1,
2.5, 5 and 10 μM (p < 0.001); (B) 2.5, 5, and 10 μM (p < 0.05); (C) 2.5, 5, and, 10 μM at (p <
0.01).
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